Clinical Trials Directory

Trials / Unknown

UnknownNCT04551612

Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma

Evaluation of the Level of Middle Cranial Fossa Dura in Patients With Cholesteatoma

Status
Unknown
Phase
Study type
Observational
Enrollment
80 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cholesteatoma is a destructive lesion that progressively expands in the middle ear, mastoid or petrous bone and leads to destruction of the nearby structures. Erosion, which is caused by bone resorption of the ossicular chain and otic capsule, may cause hearing loss, vestibular dysfunction, facial paralysis and intracranial manifestations

Detailed description

Cholesteatoma has three Classical forms: (1) Congenital, primary or genuine cholesteatoma: occurs behind an intact tympanic membrane. Primary acquired cholesteatoma: looks like a limited diverticulum of the pars flaccida with little or no history of otorrhea. Secondary acquired cholesteatoma: develops with posterosuperior perforations in eardrum and expansion of the disease process into the antrum, mastoid, attic and middle ear. Granulation tissue, polyps and foul- smelling otorrhea are common findings in this type

Conditions

Interventions

TypeNameDescription
RADIATIONMultislice computed tomography temporal bonePatients with cholesteatoma will undergo multislice computed tomography (MSCT) temporal bone images. Then The Tegmen level will be determined and compared with the other normal ear at the same patient

Timeline

Start date
2020-10-01
Primary completion
2021-10-01
Completion
2022-10-01
First posted
2020-09-16
Last updated
2020-09-17

Source: ClinicalTrials.gov record NCT04551612. Inclusion in this directory is not an endorsement.